Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,216 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a LP angle — each card surfaces how a family office could deploy capital in that market.
24 reports
Page 1 / 1- TranswesternMay 15, 2026
US Life Sciences Market Research Report - Q1 2026
LP:Family offices may also consider passive LP commitments in funds focused on late-stage life sciences investments.
- TranswesternMar 9, 2026
Houston Life Sciences Research Report - H1 2026
LP:As a passive LP, a family office could commit to funds focused on Houston's life sciences, benefiting from the sector's overall growth.
- TranswesternFeb 6, 2026
US Life Sciences Market Research Report - Q4 2025
LP:Family offices may also consider passive LP commitments in funds focused on life sciences to gain exposure to the sector.
- TranswesternNov 3, 2025
US Life Sciences Market Research Report - Q3 2025
LP:Family offices may also consider passive LP commitments in life sciences funds, although this is the least emphasized strategy given the current market dynamics.
- TranswesternSep 12, 2025
Houston Life Sciences Research Report - Summer-Fall 2025
LP:Family offices may also consider passive LP commitments in funds targeting life sciences investments to gain exposure without operational involvement.
- TranswesternAug 15, 2025
US Life Sciences Market Research Report - Q2 2025
LP:As a passive LP, a family office could commit to a fund focused on life sciences, although this approach offers less control and alignment with operators.
- TranswesternJun 6, 2025
US Life Sciences Market Research Report - Q1 2025
LP:Family offices may also consider passive LP commitments in funds targeting established life sciences operators.
- TranswesternApr 7, 2025
US Life Sciences Market Research Report - Q4 2024
LP:As a passive LP, a family office could commit to funds targeting established life sciences operators, though this approach offers less influence over asset selection.
- TranswesternMar 14, 2025
Houston Life Sciences Research Report - Winter-Spring 2025
LP:Family offices may also consider passive LP commitments in funds targeting life sciences investments in Houston.
- TranswesternFeb 7, 2025
San Francisco Life Science Research Report - Q4 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, though this approach may limit direct influence over asset management.
- TranswesternJan 17, 2025
US Life Sciences Market Research Report - Q3 2024
LP:As a passive LP, a family office can commit to funds focused on life sciences, although this approach offers less control over asset management.
- TranswesternOct 18, 2024
San Francisco Life Science Research Report - Q2 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this approach offers less control and alignment with operators.
- TranswesternSep 16, 2024
US Life Sciences Market Research Report - Q2 2024
LP:As a passive LP, a family office could commit to funds focused on life sciences, benefiting from the sector's growth without direct operational involvement.
- TranswesternSep 13, 2024
Houston Life Sciences Research Report - Summer-Fall 2024
LP:Family offices may also consider passive LP commitments in funds focused on Houston's life sciences sector.
- TranswesternJun 7, 2024
US Life Sciences Market Research Report - Q1 2024
LP:As a passive LP, a family office can gain exposure to life sciences through established funds, though this is a less emphasized strategy.
- TranswesternJun 7, 2024
Houston Life Sciences Research Report - Winter-Spring 2024
LP:Family offices may also consider passive LP commitments in funds focused on Houston's growing life sciences sector.
- TranswesternApr 19, 2024
US Life Sciences Market Research Report - Q4 2023
LP:As a passive LP, a family office could commit capital to a life sciences fund, gaining exposure to a diversified portfolio of assets.
- TranswesternFeb 16, 2024
Bay Area Life Sciences Research Report - Q4 2023
LP:Family offices can also consider passive LP commitments in life sciences funds to gain exposure to the sector without direct operational involvement.
- TranswesternDec 15, 2023
US Life Sciences Market Research Report - Q3 2023
LP:As a passive LP, a family office could commit to funds focused on life sciences, benefiting from the sector's recovery while minimizing direct involvement.
- TranswesternNov 10, 2023
Bay Area Life Sciences Research Report - Q3 2023
LP:As a passive LP, a family office could commit to a sponsor's fund, although this approach may offer less control in a fluctuating market.
- TranswesternSep 15, 2023
Houston Life Science Research Report - Summer-Fall 2023
LP:Family offices may also consider passive LP commitments in funds focused on life sciences to gain exposure to this growing market.
- TranswesternAug 4, 2023
Bay Area Life Sciences Research Report - Q2 2023
LP:The passive LP angle for a family office would involve committing capital to a sponsor's fund focused on life sciences investments.
- TranswesternApr 28, 2023
Bay Area Life Sciences Research Report - Q1 2023
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this approach offers less control compared to direct or co-GP investments.
- TranswesternApr 28, 2023
Houston Life Science Research Report - Winter-Spring 2023
LP:As a passive LP, a family office could commit to funds focused on Houston's life sciences sector, gaining exposure to a growing market.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.